Interlaminar Device Market Analysis

End-User Industry (Hospitals, Clinics, Ambulatory Surgical Centers, Skilled Nursing Facilities)

The hospitals segment in the interlaminar device market is estimated to gain a robust revenue share in the coming years owing to the increasing spending on hospitals across the globe. Hospitals may be able to invest in advanced interlaminar devices as a result of increased funding. This will also enable access to more resources within hospital premises and will lead to more patients looking for the treatment of chronic pain.

Surgery Type- (Open Surgery, Minimally Invasive Surgery)

The minimally invasive surgery segment is set to garner a notable share shortly on account of rising cases of chronic disorders. Chronic conditions such as chronic pain can be treated with minimally invasive surgery, as it causes less pain and increases the recovery rate, which often involves the use of tools including interlaminar devices, and neurostimulator devices.

Our in-depth analysis of the global market includes the following segments:

Product Type	Interspinous Distraction Devices Coflex Device
Surgery Type	Open Surgery Minimally Invasive Surgery
End User	Hospitals Clinics Ambulatory Surgical Centers Skilled Nursing Facilities

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of interlaminar device is estimated at USD 693.15 million.

The interlaminar device market size was valued at USD 629.19 million in 2024 and is likely to cross USD 1.37 billion by 2037, expanding at more than 6.2% CAGR during the forecast period i.e., between 2025-2037. Growing Cases of Sports Injuries and the growing advancements in spine surgery technologies across the globe will boost the market growth.

North America industry is anticipated to account for largest revenue share of 38% by 2037, impelled by rising adoption of interlaminar devices in the region.

The major players in the market are NuVasive, Inc., Zimmer Biomet, Life Spine, Inc., Xtant Medical, Alphatec Holdings, Inc., Amedica Corporation, Paradigm Health System, Bioventus LLC, Medical Device Business Services, Inc., Meditech Spine, LLC

Interlaminar Device Market Analysis